Environmental, Social And Governance Report

Overview

The report describes Alphamab Oncology's 2023 progress in innovative oncology medicines, including RMB 408 million of R&D investment. Environmental KPIs include 35,063.56 '000kWh of total energy consumption and 12,760.81 tonnes of Scope 1 and Scope 2 greenhouse gas emissions. The company reported 435 regular full-time employees, 100% employee training, and zero work-related fatalities. It also donated over 220,000 ENWEIDA vials, equivalent to RMB 132 million, through its patient relief program.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2023
Period: 1 January 2023 – 31 December 2023
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Materiality

Assessment
Basis
Matrix

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services